Subscribe To
Bofa downgrades ionis after vupanorsen setback: are there upcoming catalysts that can help the stock?
Ionis Pharmaceuticals Inc IONS announced on Monday the discontinuation of the Vupanorsen clinical development program. Following this, there are no h...
February 1, 2022, 12:21 pm
Bofa downgrades ionis after vupanorsen setback: are there upcoming catalysts that can help the stock?
Ionis Pharmaceuticals Inc IONS announced on Monday the discontinuation of the Vupanorsen clinical development program. Following this, there are no h...
February 1, 2022, 12:21 pm
Let the trends be your friends with microsoft stock
After the Fed successfully threaded the needle, the Street is warming up to Microsoft again, and MSFT stock has multiple, positive, other...
January 31, 2022, 2:10 pm
Let the trends be your friends with microsoft stock
After the Fed successfully threaded the needle, the Street is warming up to Microsoft again, and MSFT stock has multiple, positive, other...
January 31, 2022, 2:10 pm
Let the trends be your friends with microsoft stock
After the Fed successfully threaded the needle, the Street is warming up to Microsoft again, and MSFT stock has multiple, positive, other...
January 31, 2022, 2:10 pm
Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch
One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up...
January 31, 2022, 12:07 pm
Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch
One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up...
January 31, 2022, 12:07 pm
Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch
One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up...
January 31, 2022, 12:07 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant. Late-stage failures of antidepressants are not...
January 28, 2022, 1:06 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant. Late-stage failures of antidepressants are not...
January 28, 2022, 1:06 pm
4 clinical catalysts on tap for relmada in 2022
RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant. Late-stage failures of antidepressants are not...
January 28, 2022, 1:06 pm
Lucid stock is poised to rebound once investors regain their senses
A strong orderbook, aggressive expansion plans and new vehicle launches should be the major growth catalysts...
January 28, 2022, 12:39 pm
Lucid stock is poised to rebound once investors regain their senses
A strong orderbook, aggressive expansion plans and new vehicle launches should be the major growth catalysts...
January 28, 2022, 12:39 pm
Lucid stock is poised to rebound once investors regain their senses
A strong orderbook, aggressive expansion plans and new vehicle launches should be the major growth catalysts...
January 28, 2022, 12:39 pm
Apple's size allows 'flexibility with the supply chain': analyst
Cowen Analyst for Semiconductor Equipment, Manufacturing & IT Hardware Krish Sankar joins Yahoo Finance Live to discuss historic first quarter revenue...
January 28, 2022, 11:14 am
Apple's size allows 'flexibility with the supply chain': analyst
Cowen Analyst for Semiconductor Equipment, Manufacturing & IT Hardware Krish Sankar joins Yahoo Finance Live to discuss historic first quarter revenue...
January 28, 2022, 11:14 am
Apple's size allows 'flexibility with the supply chain': analyst
Cowen Analyst for Semiconductor Equipment, Manufacturing & IT Hardware Krish Sankar joins Yahoo Finance Live to discuss historic first quarter revenue...
January 28, 2022, 11:14 am